2. Academic Validation
  3. PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 Klebsiella pneumoniae isolate

PKPD modeling of the inoculum effect of combined ceftazidime/avibactam and colistin against KPC-3 Klebsiella pneumoniae isolate

  • Antimicrob Agents Chemother. 2025 May 7;69(5):e0179724. doi: 10.1128/aac.01797-24.
Romain Aubry 1,  Julien M Buyck 1,  Alexia Chauzy 1,  Laure Prouvensier 1 2,  Jean-Winoc Decousser 3 4,  Patrice Nordmann 5 6 7,  Sebastian G Wicha 8,  Sandrine Marchand 1 2,  Nicolas Grégoire 1 2
Affiliations

Affiliations

  • 1 INSERM U1070 PHAR2, Université de Poitiers, Poitiers, Nouvelle-Aquitaine, France.
  • 2 Laboratoire de Toxicologie et de Pharmacocinétique, CHU de Poitiers, Poitiers, Nouvelle-Aquitaine, France.
  • 3 Department of Bacteriology and Infection Control, University Hospital Henri Mondor, Assistance Publique-Hôpitaux de Paris, Créteil, France.
  • 4 EA 7380 Dynamyc Université Paris-Est Créteil (UPEC), Ecole nationale vétérinaire d'Alfort (EnvA), Faculté de Médecine de Créteil, Créteil, France.
  • 5 Medical and Molecular Microbiology, Faculty of Science and Medicine, University of Fribourg, Fribourg, Switzerland.
  • 6 Swiss National Reference Center for Emerging Antibiotic Resistance (NARA), University of Fribourg, Fribourg, Switzerland.
  • 7 Institute for Microbiology, University of Lausanne and University Hospital Centre, Lausanne, Switzerland.
  • 8 Department of Clinical Pharmacy, Institute of Pharmacy, University of Hamburg, Hamburg, Germany.
PMID: 40227072 DOI: 10.1128/aac.01797-24
Abstract

The inoculum effect (IE) characterizes a decrease in the antimicrobial effect of Antibiotics with increasing inoculum. To face antimicrobial resistance, Antibiotic combinations are progressively used. In this context, the effect of combination may be affected by IE, especially drugs for which an IE has been described. The objective was to characterize the IE of a carbapenemase (KPC-3) Klebsiella pneumoniae isolate on the combination of ceftazidime/avibactam (CZA) and colistin (CST). In vitro time-kill curves with single and combined drugs were performed at four different inocula. The IE of each drug was described using pharmacokinetic/pharmacodynamic modeling, and interactions on IE were investigated with the general pharmacodynamic interaction model when drugs were combined. The IE was assessed by evaluating the significance of the parameters associated with the IE model compared to the no IE model and by comparing the CFU counts over time predicted with the IE model vs the no IE model. Rapid Bacterial killing was observed at 104 CFU/mL. For both 5·105 and 107 CFU/mL inocula, initial decays followed by re-growth were observed with drugs alone, while the combination prevented the emergence of resistance. Eradication was never achieved at 108 CFU/mL. The IE was best modeled as a reduction of CZA maximum bactericidal effect and as an increase in CST EC50 with increasing inoculum. However, no interaction between IEs was significant, meaning that CST did not modify the IE of CZA and inversely. IE may be important at least as demonstrated by in vitro Antibiotic combination studies.

Keywords

PKPD modeling; antimicrobial combination; ceftazidime/avibactam; colistin; inoculum effect.

Figures
Products